For past Congresses, use the Browse menu.
HR 741
112th Congress • 2011–2013 (Ended)

To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.


Organizations below reported lobbying activity that included this bill as a disclosed issue. Expand to view filing details.
Loading filings…